Venrock
Venture Capital
Active
Palo Alto, United States
823
26M
431
14.96
125
0.48
253
- Stages of investment
- Areas of investment
Summary
In 1969 was created Venrock, which is appeared as VC. The main department of described VC is located in the Palo Alto. The company was established in North America in United States.
The fund is constantly included in 25-48 deals per year. The important activity for fund was in 2007. Despite it in 2019 the fund had an activity. The higher amount of exits for fund were in 2014. The common things for fund are deals in the range of 10 - 50 millions dollars. The typical startup value when the investment from Venrock is 100-500 millions dollars. Opposing the other organizations, this Venrock works on 2 percentage points less the average amount of lead investments. Speaking about the real fund results, this VC is 8 percentage points more often commits exit comparing to other organizations.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Venrock, startups are often financed by Third Rock Ventures, OrbiMed, Lux Capital. The meaningful sponsors for the fund in investment in the same round are Trellis Partners, Sequoia Capital, Investor Growth Capital Limited. In the next rounds fund is usually obtained by MPM Capital, Investor Growth Capital Limited, Sequoia Capital.
The overall number of key employees were 14.
For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has no exact preference in a number of founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Juno Therapeutics, AveXis, Receptos. Among the most popular fund investment industries, there are Health Care, Information Technology.
Investor highlights
- Industry generalist
- Yes
- Industry focus
- Stage focus
- Geo focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Last fund
- Fund size
- USD 650000000
- Fund raised date
- 2024-01-08
Analytics
- Total investments
- 823
- Lead investments
- 125
- Exits
- 253
- Rounds per year
- 14.96
- Follow on index
- 0.48
- Investments by industry
- Health Care (241)
- Biotechnology (204)
- Software (175)
- Medical (124)
- Information Technology (102) Show 268 more
- Investments by region
-
- United States (770)
- Canada (8)
- China (5)
- Switzerland (4)
- United Kingdom (5) Show 7 more
- Peak activity year
- 2007
- Number of Unicorns
- 37
- Number of Decacorns
- 38
- Number of Minotaurs
- 14
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 19
- Avg. valuation at time of investment
- 365M
- Group Appearance index
- 0.84
- Avg. company exit year
- 10
- Avg. multiplicator
- 2.78
- Strategy success index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Bright Peak Therapeutics | 11 Jun 2024 | Biotechnology, Therapeutics | Late Stage Venture | 90M | Switzerland, Basel-City, Basel |
Moment | 14 Sep 2023 | Financial Services, FinTech, Analytics, Risk Management | Early Stage Venture | 17M | United States, New York, New York |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.